Skip to main content

Advertisement

Log in

Modulation of factors involved in placental haemostasis and angiogenesis by low-molecular-weight-heparins

  • Gynecologic Endocrinology and Reproductive Medicine
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Purpose

In placentae from uneventful pregnancies a direct relationship between expression of tissue factor (TF) and tissue-factor pathway inhibitor type 2 (TFPI2) was found, as well as between TF and vascular endothelial growth factor (VEGF). Furthermore, placentae from gestational vascular complications (GVCs) lack these correlations. Aims of the present study are (1) to evaluate a possible role of low-molecular-weight-heparins (LMWHs) in the modulation of the expression of TF, TFPI, TFPI2 and VEGF in placentae from thrombophilic women and (2) to study the possible role of endothelium in the placental expression of markers involved in haemostasis and angiogenesis.

Methods

Fourteen pregnancies in thrombophilic women and 11 uneventful pregnancies in non-thrombophilic women were studied and placentae collected. From each placenta total RNA was obtained. Expression of TF, TFPI, TFPI2 and VEGF was evaluated. Human Vein Endothelial Cells were incubated with increasing doses of LMWH and expression of TF, TFPI and VEGF was measured.

Results

Expression of all the markers analyzed in placentae from treated pregnancies was similar to that observed in placentae from uneventful ones. A significant direct relationship between TF and TFPI2, as well as TF and VEGF, was observed in cases treated with LMWHs and controls. Furthermore, the expression of TF and its inhibitors and VEGF in endothelial cells was modulated by LMWH.

Conclusion

Present data suggest that LMWH during pregnancy in thrombophilic women restores the relationship between markers of haemostasis and angiogenesis. Furthermore, the endothelium is likely to play an important role in this phenomenon.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Erlich J, Parry GCN, Fearns C et al (1999) Tissue factor is required for uterine haemostasis and maintenance of the placental labyrinth during gestation. Proc Natl Acad Sci 96:8138–8143

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Abe K, Shoji M, Chen J et al (1999) Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor. Proc Natl Acad Sci 96:8663–8668

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Parry GC, Mackman N (2000) Mouse embryogenesis requires the tissue factor extracellular domain but not the cytoplasmic domain. J Clin Invest 105:1547–1554

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Aharon A, Brenner B, Katz T, Miyagi Y, Lanir N (2004) Tissue factor and tissue factor pathway inhibitor levels in trophoblast cells: implications for placental haemostasis. Thromb Haemost 92:776–786

    CAS  PubMed  Google Scholar 

  5. Wulff C, Wilson H, Dickson SE, Wiegand SJ, Fraser HM (2002) Hemochorial placentation in the primate: expression of vascular endothelial growth factor, angiopoietins, and their receptors throughout pregnancy. Biol Reprod 66:802–812

    Article  CAS  PubMed  Google Scholar 

  6. Zhou Y, McMaster M, Woo K, Janatpour M, Perry J, Karpanen T, Alitalo K, Damsky C, Fisher SJ (2002) Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol 160:1405–1423

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Kaufmann P, Black S, Huppertz B (2003) Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod 69:1–7

    Article  CAS  PubMed  Google Scholar 

  8. Saito T, Takeda N, Amiya E, Nakao T, Abe H, Semba H, Soma K, Koyama K, Hosoya Y, Imai Y, Isagawa T, Watanabe M, Manabe I, Komuro I, Nagai R, Maemura K (2013) VEGF-A induces its negative regulator, soluble form of VEGFR-1, by modulating its alternative splicing. FEBS Lett 587(14):2179–2185. doi:10.1016/j.febslet.2013.05.038

    Article  CAS  PubMed  Google Scholar 

  9. Fan X, Rai A, Kambham N, Sung JF, Singh N, Petitt M, Dhal S, Agrawal R, Sutton RE, Druzin ML, Gambhir SS, Ambati BK, Cross JC, Nayak NR (2014) Endometrial VEGF induces placental sFLT1 and leads to pregnancy complications. J Clin Invest. 124(11):4941–4952. doi:10.1172/JCI76864

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Chinni E, Colaizzo D, Margaglione M et al (2008) Correlation between factors involved in the local haemostasis and angiogenesis in full term human placenta. Thromb Res 122:376–382. doi:10.1016/j.thromres.2007.12.016

    Article  CAS  PubMed  Google Scholar 

  11. Chinni E, Colaizzo D, Tiscia GL et al (2010) Markers of haemostasis and angiogenesis in placentae from gestational vascular complications: impairment of mechanisms involved in maintaining intervillous blood flow. Thromb Res 125:267–271. doi:10.1016/j.thromres.2009.09.024

    Article  CAS  PubMed  Google Scholar 

  12. Grandone E, Tomaiuolo M, Colaizzo D, Ames PR, Margaglione M (2009) Role of thrombophilia in adverse obstetric outcomes and their prevention using antithrombotic therapy. Semin Thromb Hemost 35(7):630–643. doi:10.1055/s-0029-1242717

    Article  CAS  PubMed  Google Scholar 

  13. Kupferminc MJ, Fait G, Many A, Lessing JB, Yair D, Bar-Am A, Eldor A (2001) Low molecular weight heparin for the prevention of obstetric complications in women with thrombophilia. Hypert Pregn 20:35–44

    Article  CAS  Google Scholar 

  14. Ceccarelli M, Bani D, Cinci L, Nistri S, Uliva C, Ragazzo E, Vannacci A, Manoni M, Gori AM, Abbate R, Gensini GF, Masini E (2009) Anti-inflammatory effects of low molecular weight heparin derivative in a rat model of carrageenan-induced pleurisy. J Cell Mol Med 13:2704–2712. doi:10.1111/j.1582-4934.2009.00658.x

    Article  PubMed  Google Scholar 

  15. Practice Committee of the American Society for Reproductive Medicine (2008) Definitions of infertility and recurrent pregnancy loss. Fertil Steril 89:1603

    Article  Google Scholar 

  16. Parazzini F, Cortinovis I, Bortolus R, Fedele L, Recarli A (1995) Weight at birth by gestational age in Italy. Hum Reprod 10:1862–1863

    CAS  PubMed  Google Scholar 

  17. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCt method. Methods 25:402–408

    Article  CAS  PubMed  Google Scholar 

  18. Jaffe EA, Nachman RL, Becker CG, Minick CR (1973) Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 52:2745–2756

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Paidas M, Ku DH, Triche E, Lockwood C, Arkel Y (2004) Does heparin therapy improve pregnancy outcome in patients with thrombophilias? J Thromb Haemost 2:1194–1195

    Article  CAS  PubMed  Google Scholar 

  20. Urban G, Vergani P, Tironi R, Ceruti P, Vertemati E, Sala F, Pogliani E, Triche EW, Lockwood CJ, Paidas MJ (2007) Antithrombotic prophylaxis in multiparous women with preeclampsia or intrauterine growth retardation in an antecedent pregnancy. Int J Fertil Womens Med 52:59–67

    PubMed  Google Scholar 

  21. Grandone E, De Stefano V, Rossi E, Cappucci F, Colaizzo D, Margaglione M (2008) Antithrombotic prophylaxis during pregnancy in women with deficiency of natural anticoagulants. Blood Coagul Fibrinolysis 19:226–230. doi:10.1097/MBC.0b013e3282f54545

    Article  CAS  PubMed  Google Scholar 

  22. Shen BQ, Lee DY, Cortopassi KM, Damico LA, Zioncheck TF (2001) Vascular endothelial growth factor KDR receptor signaling potentiates tumor necrosis factor-induced tissue factor expression in endothelial cells. J Biol Chem 276:5281–5286

    Article  CAS  PubMed  Google Scholar 

  23. Thadhani R, Kisner T, Hagmann H, Bossung V, Noack S, Schaarschmidt W, Jank A, Kribs A, Cornely OA, Kreyssig C, Hemphill L, Rigby AC, Khedkar S, Lindner TH, Mallmann P, Stepan H, Karumanchi SA, Benzing T (2011) Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia. Circulation 124(8):940–950. doi:10.1161/CIRCULATIONAHA.111.034793

Download references

Acknowledgments

We thank Dr. E. Mangiullo for collecting samples.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Elvira Grandone.

Ethics declarations

Conflict of interest

The authors declare that they have no conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Grandone, E., Chinni, E., Villani, M. et al. Modulation of factors involved in placental haemostasis and angiogenesis by low-molecular-weight-heparins. Arch Gynecol Obstet 294, 1323–1329 (2016). https://doi.org/10.1007/s00404-016-4185-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-016-4185-8

Keywords

Navigation